186 related articles for article (PubMed ID: 32462525)
1. ASO Author Reflections: Pancreatic Invasion is a Crucial Independent Prognostic Factor in Duodenal Carcinoma.
Nitta N; Ohgi K; Sugiura T; Okamura Y; Ito T; Yamamoto Y; Ashida R; Sasaki K; Uesaka K
Ann Surg Oncol; 2020 Oct; 27(11):4561. PubMed ID: 32462525
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Prognostic Value of Tumor Deposits in Resected Pancreatic Ductal Adenocarcinoma.
Hua J; Shi S
Ann Surg Oncol; 2023 May; 30(5):3045. PubMed ID: 36695995
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail.
Kitamura K; Esaki M; Sone M; Sugawara S; Hiraoka N; Nara S; Ban D; Takamoto T; Mizui T; Shimada K
Ann Surg Oncol; 2022 Oct; 29(11):7059-7060. PubMed ID: 35648319
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Prognostic Index after Neoadjuvant Chemotherapy (PINC) in Pancreatic Ductal Adenocarcinoma as Novel Tumor Regression Grading System.
Redegalli M; Schiavo Lena M
Ann Surg Oncol; 2022 Jun; 29(6):3503. PubMed ID: 35187623
[No Abstract] [Full Text] [Related]
5. Duodenal Involvement is an Independent Prognostic Factor for Patients with Surgically Resected Pancreatic Ductal Adenocarcinoma.
Dal Molin M; Blackford AL; Siddiqui A; Brant A; Cho C; Rezaee N; Yu J; He J; Weiss M; Hruban RH; Wolfgang C; Goggins M
Ann Surg Oncol; 2017 Aug; 24(8):2379-2386. PubMed ID: 28439733
[TBL] [Abstract][Full Text] [Related]
6. ASO Author Reflections: Accurate Evaluation of Malignant Potential in Pancreatic Ductal Adenocarcinoma Using DUPAN-2 Level.
Sumiyoshi T; Uemura K
Ann Surg Oncol; 2024 Jul; 31(7):4697. PubMed ID: 38739237
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma.
Malleo G; Maggino L; Fernàndez-Del Castillo C; Salvia R
Ann Surg Oncol; 2020 Oct; 27(10):3913-3914. PubMed ID: 32399766
[No Abstract] [Full Text] [Related]
8. ASO Author Reflections: The Need for Improvement of the 8th American Joint Committee on Cancer TNM Staging System for Resected Pancreatic Ductal Adenocarcinoma.
Schouten TJ; Daamen LA; van Santvoort HC; Molenaar IQ
Ann Surg Oncol; 2022 Sep; 29(9):6000-6001. PubMed ID: 35441304
[No Abstract] [Full Text] [Related]
9. [Pathological analysis of pancreatic colloid carcinoma in 7 cases].
Min X; Guo JZ; Zhan Q
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):377-8. PubMed ID: 17892136
[No Abstract] [Full Text] [Related]
10. Preoperative Multidetector CT Diagnosis of Extrapancreatic Perineural or Duodenal Invasion Is Associated with Reduced Postoperative Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Preliminary Experience and Implications for Patient Care.
Chang ST; Jeffrey RB; Patel BN; DiMaio MA; Rosenberg J; Willmann JK; Olcott EW
Radiology; 2016 Dec; 281(3):816-825. PubMed ID: 27438167
[TBL] [Abstract][Full Text] [Related]
11. ASO Author Reflections: Do Distinct Patterns of Recurrence Impact the Prognosis of Patients With Resected Pancreatic Ductal Adenocarcinoma?
Groot VP; Wolfgang CL; He J
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):806-807. PubMed ID: 30298312
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Timing of Systemic Therapy and Postoperative Morbidity in Resectable Pancreatic Ductal Adenocarcinoma and Distal Cholangiocarcinoma.
Macfie R; Cohen N
Ann Surg Oncol; 2023 Aug; 30(8):5035. PubMed ID: 37179272
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Rethinking Spleen Preservation in Patients with Body Pancreatic Ductal Adenocarcinoma.
Hobeika C; Sauvanet A
Ann Surg Oncol; 2024 Jul; 31(7):4691-4692. PubMed ID: 38649552
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: Postoperative Carbohydrate Antigen 19-9 Levels Become a Reliable Biomarker for Establishing Intensity-Stratified Adjuvant Treatments in Pancreatic Ductal Adenocarcinoma.
Ariake K; Okada T; Tsuchiya H; Kuboki D; Maemura K; Ichikawa H; Tachibana T; Akazawa N; Abe T; Kakita T; Oikawa M; Tsuchiya T
Ann Surg Oncol; 2024 Jan; 31(1):548-549. PubMed ID: 37907696
[No Abstract] [Full Text] [Related]
15. ASO Author Reflections: R Status Is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma.
Crippa S; Giannone F; Lena MS; Falconi M
Ann Surg Oncol; 2021 Aug; 28(8):4613-4614. PubMed ID: 33586067
[No Abstract] [Full Text] [Related]
16. ASO Author Reflections: Prognostic Value of the Preoperative Tumor Marker Index in Resected Pancreatic Ductal Adenocarcinoma: A Retrospective Single Institutional Study.
Miyata T; Hayashi H; Baba H
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):903-904. PubMed ID: 32840745
[No Abstract] [Full Text] [Related]
17. ASO Author Reflections: Estimation of Intraoperative Superior Mesenteric-Portal Vein Involvement in Pancreatic Ductal Adenocarcinoma on Preoperative CT-Radiomics Provides Better Performance.
Zhou Y; Chen FM
Ann Surg Oncol; 2023 Feb; 30(2):1217-1218. PubMed ID: 36350457
[No Abstract] [Full Text] [Related]
18. Clinicopathological Stratification and Long-term Follow-up of Patients with Periampullary Carcinomas.
Schmuck RB; Brokat C; Andreou A; Felsenstein M; Klein F; Sinn B; Pratschke J; Bahra M
Anticancer Res; 2018 Sep; 38(9):5379-5386. PubMed ID: 30194192
[TBL] [Abstract][Full Text] [Related]
19. ASO Author Reflections: Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma.
Tamburrino D; Guarneri G; Capurso G; Falconi M
Ann Surg Oncol; 2021 Apr; 28(4):2323-2324. PubMed ID: 32929602
[No Abstract] [Full Text] [Related]
20. ASO Author Reflections: The Clinical Dilemma of Para-Aortic Dissection in Pancreaticoduodenectomy for Ductal Adenocarcinoma.
Shen Z; Chen H; Ji Y; Wang W; Shen B
Ann Surg Oncol; 2023 Mar; 30(3):1483-1484. PubMed ID: 36303081
[No Abstract] [Full Text] [Related]
[Next] [New Search]
